Transglutaminase 2–mediated glutamine deamidation enhances p21 stability during senescence
Open Access
- 11 June 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (24)
Abstract
The limited doubling capacity of human cells, known as replicative senescence or cellular senescence, is a major factor in cellular aging. This process is triggered by telomere erosion, which activates a p53-mediated DNA damage response (DDR) that halts cell proliferation. p53, a transcriptional regulator, responds to DNA damage by increasing the expression of the cyclin-dependent kinase inhibitor p21. p21 then arrests cells at specific stages of the cell cycle. Additionally, p53 upregulates serpinB2 (also known as plasminogen activator inhibitor-2, PAI-2), which stabilizes p21 in senescent cells. This study reveals that serpinB2 upregulation activates transglutaminase 2 (TGM2), which selectively deamidates multiple glutamine residues on p21, stabilizing the protein and halting cell proliferation in senescent cells. Moreover, inhibiting TGM2-mediated deamidation accelerates p21 degradation, delaying the onset of senescence. Notably, pharmacological inhibition of TGM2 improves aging phenotypes in an accelerated aging model of chronic kidney disease (CKD). These findings provide crucial insights into the role of TGM2-mediated enzymatic deamidation in senescence and its potential relevance to age-associated conditions.Keywords
Funding Information
- National Health Research Institutes (NHRI-12A1-CG-CO-08-2325-2)
- National Science and Technology Council (NSTC 109-2311-B-002-014-MY3)
- National Science and Technology Council (NSTC 111-2311-B-002-009-MY3)
This publication has 42 references indexed in Scilit:
- Transglutaminase 2 as a novel target in chronic kidney disease – Methods, mechanisms and pharmacological inhibitionPharmacology & Therapeutics, 2021
- Chronic Kidney DiseaseThe American Journal of Pathology, 2020
- Tumour suppression by p53: the importance of apoptosis and cellular senescenceThe Journal of Pathology, 2009
- Transglutaminase 2 inhibitors and their therapeutic role in disease statesPharmacology & Therapeutics, 2007
- Accumulation of senescent cells in mitotic tissue of aging primatesMechanisms of Ageing and Development, 2007
- Chromosome positional effects of gene expressions after cellular senescenceBiochemical and Biophysical Research Communications, 2003
- Transglutaminase activity in aging articular chondrocytes and articular cartilage vesiclesArthritis & Rheumatism, 1997
- Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescenceExperimental Gerontology, 1996
- The limited in vitro lifetime of human diploid cell strainsExperimental Cell Research, 1965
- The serial cultivation of human diploid cell strainsExperimental Cell Research, 1961